Akeso plans strategic share placement, maintains capital

For the month ended August 31, 2025, Akeso, Inc. reported no change to its authorized share capital, which remains at 5bn ordinary shares with a par value of $0.00001 per share, totaling $50,000. The number of issued shares also held steady at 897,593,176. No movements in issued or treasury shares occurred during the month from share option exercises or other arrangements.

The company's Post-IPO Share Option Scheme, adopted in 2022 and amended in 2024, had 7,473,000 options outstanding at month-end. Of these, 202,000 shares may be issued upon exercise, with a total of 76,050,717 shares potentially issuable under the scheme. The scheme limit on grants of share options and awards was amended to 86,585,717 shares after the annual general meeting on June 30, 2024.

Akeso, Inc. also disclosed a conditional agreement on August 28, 2025, to allot and issue 23,550,000 primary placing shares at HK$149.54 per share. This placement, to be executed under the General Mandate, will increase the total number of issued shares, though the shares have not yet been allotted or issued as of the reporting date.